Recorded as renamed to Medtronic Ardian Luxembourg S.A.R.L. (2012)
Previously recorded as Ardian, Inc. (to 2012)
41 patents currently held
27 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Aug 2027. from the record
Of the 27 now held by other companies, 15 name Medtronic Ireland Manufacturing Unlimited Company as their current owner, and 12 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
3
Ending by 2030
Aug 2027
Next term end
25
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2032 · Medium confidence
Also notable
Ends no later than Jun 2029 · Low confidence
Also notable
Ends Jul 2033 · High confidence
Also notable
Ends Aug 2035 · High confidence
Also notable
Ends May 2035 · High confidence
Also notable
Ends Oct 2031 · High confidence
Also notable
Ends Oct 2033 · High confidence
Also notable
Ends no later than Dec 2038 · Medium confidence
Methods and Systems for Thermally-Induced Renal Neuromodulation
US 9,345,900
The most cited patent in this portfolio, cited by 1,020 later US patents, top 1% of utility patents granted in 2016 in our data. Protection runs to 2032.
Apparatus, Systems, and Methods for Achieving Intravascular, Thermally-Induced Renal Neuromodulation
US 8,777,942
Cited by 333 later US patents, top 1% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Multi-Electrode Catheter Assemblies for Renal Neuromodulation and Associated Systems and Methods
US 8,888,773
Cited by 80 later US patents, top 10% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2033.
Therapeutic Renal Neuromodulation for Treating Dyspnea and Associated Systems and Methods
US 10,292,754
Cited by 34 later US patents, top 10% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2035.
Controlled Neuromodulation Systems and Methods of Use
US 10,543,037
Cited by 19 later US patents, top 10% of utility patents granted in 2020 in our data. Protection runs to 2035.
Microwave Catheter Apparatuses, Systems, and Methods for Renal Neuromodulation
US 10,182,865
Cited by 16 later US patents, top 25% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2031.
Multi-Electrode Apposition Judgment Using Pressure Elements
US 9,066,726
Cited by 18 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2033.
Methods for Treating Depression in Patients via Renal Neuromodulation
US 10,945,788
Cited by 9 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2038. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 6, 2027The maintenance fee for Devices and Associated Methods for Monitoring of Neuromodulation Using Biomarkers (US 10,368,791) comes due Feb 6, 2027. Unpaid by Aug 6, 2027, it lapses early.
- 1 fee due Mar 22, 2027The maintenance fee for Multi-Electrode Catheter Assemblies for Renal Neuromodulation and Associated Systems and Methods (US 9,138,292) comes due Mar 22, 2027. Unpaid by Sep 22, 2027, it lapses early.
- 1 fee due Apr 8, 2027The maintenance fee for Multi-Electrode Apposition Judgment Using Pressure Elements (US 10,433,905) comes due Apr 8, 2027. Unpaid by Oct 8, 2027, it lapses early.
- 1 fee due Jun 24, 2027The maintenance fee for Multi-Electrode Catheter Assemblies for Renal Neuromodulation and Associated Systems and Methods (US 10,512,504) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
- 1 fee due Jul 28, 2027The maintenance fee for Controlled Neuromodulation Systems and Methods of Use (US 10,543,037) comes due Jul 28, 2027. Unpaid by Jan 28, 2028, it lapses early.
- 1 fee due Aug 18, 2027The maintenance fee for Neuromodulation Systems and Methods for Treatment of Sexual Dysfunction (US 10,561,460) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.
Recent changes
- 3 of the patents on this record were granted since Aug 23, 2026
What they patent
The largest of its 25 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,620,451 | Methods and Apparatus for Pulsed Electric Field Neuromodulation via an Intra-To-Extravascular Approach In force · High confidence | In force | High confidence | |
| US 8,777,942 | Apparatus, Systems, and Methods for Achieving Intravascular, Thermally-Induced Renal Neuromodulation In force · Low confidence | In force | Low confidence | |
| US 10,561,460 | Neuromodulation Systems and Methods for Treatment of Sexual Dysfunction In force · Medium confidence | In force | Medium confidence | |
| US 9,345,530 | Devices, Systems and Methods for Evaluation and Feedback of Neuromodulation Treatment In force · High confidence | In force | High confidence | |
| US 9,750,560 | Devices, Systems and Methods for Evaluation and Feedback of Neuromodulation Treatment In force · Low confidence | In force | Low confidence | |
| US 10,179,020 | Devices, Systems and Methods for Evaluation and Feedback of Neuromodulation Treatment In force · Low confidence | In force | Low confidence | |
| US 10,182,865 | Microwave Catheter Apparatuses, Systems, and Methods for Renal Neuromodulation In force · High confidence | In force | High confidence | |
| US 11,006,999 | Devices, Systems and Methods for Evaluation and Feedback of Neuromodulation Treatment In force · Low confidence | In force | Low confidence | |
| US 11,129,674 | Microwave Catheter Apparatuses, Systems, and Methods for Renal Neuromodulation In force · High confidence | In force | High confidence | |
| US 10,188,445 | Neuromodulation Cryotherapeutic Devices and Associated Systems and Methods In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 41: 27 patents in force now held by others · 101 patents ended · 18 applications pending · 33 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.